The litigation, Wistisen v. Alibaba Group Holding Limited, alleges that the company and its CEO violated the Securities Exchange Act of 1934 by failing to disclose critical ties to the Chinese military and engaging in unauthorized AI model distillation. According to the complaint, Alibaba allegedly concealed that it was under the control of the Chinese Ministry of Industry and Information Technology, a designation that led the U.S. Department of Defense to officially identify the firm as a Chinese military company on June 8, 2026. This disclosure triggered a nearly 4% drop in the company's American Depositary Shares.

Further pressure mounted on June 24, 2026, when Bloomberg reported that the AI firm Anthropic accused entities linked to Alibaba’s Qwen lab of illicitly accessing and distilling proprietary technology from Claude models. The lawsuit claims that Alibaba’s public statements regarding its business operations were materially misleading, resulting in significant financial losses for shareholders as the stock price fell following these revelations. Robbins Geller Rudman & Dowd LLP is representing the class, and investors seeking to serve as lead plaintiff must move before the October deadline.